Quantitative EEG in the prediction of antidepressant response to imipramine

Journal of Affective Disorders

Volumn 39, Issue 3, 1996, Pages 175-184

  Knott, Verner J ^a   Telner, John I ^a   Lapierre, Yvon D ^a   Browne, Michael ^a   Horn, Edward R ^a  

^a ROYAL OTTAWA HOSPITAL   (Canada)

Author keywords

Antidepressant; Depression; EEG; Imipramine; Non responder; Responder

Indexed keywords

IMIPRAMINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC VALUE; DRUG EFFECT; ELECTROENCEPHALOGRAM; HUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS;

EID: 0030605804     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-0327(96)00003-1     Document Type: Article

References (43)

1. Abt, K. (1987) Descriptive data analysis: A concept between confirmatory and exploratory data analysis. Methods Inf. Med. 26, 77-88.
2. Asberg, M., Bertilsson, L., Tuck, D., Cronholm, B. and Sjdquist, F. (1978) Indoleamine metabolites in cerebrospinal fluid of depressed patients before and during treatment with nortriptyline. Clin. Pharmacol. Ther. 14, 277-286.
3. Bielski, R. and Friedel, R.O. (1976) Prediction of tricyclic antidepressant response: a critical review. Arch. Gen. Psychiatry 88. 1479-1489.
4. Blom, J. and Anneveldt, N. (1982) An electrode cap tested. Electroenceph. Clin. Neurophysiol. 54, 591-594.
5. Brown, W., Johnston, R. and Mayfield, D. (1979) The 24-hour dexamethasone suppression test in a clinical setting: relationship to diagnosis, symptoms, and response to treatment. Am. J. Psychiatry 136, 543-547.
6. Brown, W., Haier, R. and Qualls, C. (1980) Dexamethasone suppression test identifies subtypes of depression which respond to different antidepressants. Lancet i, 928-929.
7. Buchsbaum, M., Lee, S., Haier, R.J., Green, M. and Tang, S.W. (1988) Effects of amoxapine and imipramine on cerebral glucose metabolism assessed by positron emission tomography. J. Clin. Psychiatry Monogr. 4, 14-17.
8. Coppola, R. and Herrmann, W. (1987) Psychotropic drug profiles: comparison by topographic maps of absolute power. Neuropsychobiology 18, 97-104.
9. Cowdry, R.W. and Goodwin, F.K. (1981) Biological and physiological predictors of drug response. In H.M. van Praag et al. (Eds.), Handbook of Biological Psychiatry. Marcel Dekker, New York, NY, pt. 6, pp. 263-308.
10. Fahndrich, E. and Herrmann, W. (1985) The search for electroencephalographic variables which could predict the efficacy of antidepressants. Pharmacopsychiatry 18, 108-109.
11. Fawcett, J. and Siomopoulos, V. (1971) Dextroamphetamine response as a possible predictor of improvement with tricyclic therapy in depression. Arch. Gen. Psychiatry 25, 247-255.
12. Fink, M. (1980) An objective classification of psychoactive drugs. Prog. Neuro-Psychopharmacol. 4, 495-502.
13. Friedel, R.O. (1982) The relationship of therapeutic response to antidepressant plasma levels: an update. J. Clin. Psychiatry 43, 37-42.
14. Gasser, T., Bacher, P. and Mocks, J. (1982) Transformation towards the normal distribution of broad band spectral parameters of the EEG. Electroencephal. Clin. Neurophysiol. 53, 119-124.
15. Grenblatt, M., Grosser, G.H. and Wechsler, H. (1964) Differential response of hospitalized depressed patients to somatic therapy. Am. J. Psychiatry 120, 935-943.
16. Herrmann, W. (1982a) (Ed.) Electroencephalography in Drug Research. Gustav Fischer Verlag, Stuttgart.
17. Herrmann, W. (1982b) Development and critical evaluation of an objective procedure for the electroencephalographic classification of psychotropic drugs. In W. Herrmann (Ed.), Electroencephalography in Drug Research. Gustav Fischer, Stuttgart, pp. 249-324.
18. Herrmann, W. and Irrgang, V. (1983) An absolute must in clinico-pharmacological research: pharmaco-electroencephalography, its possibilities and limitations. Pharmacopsychiatry 16, 134-142.
19. Herrmann, W. and Schaerer, E. (1986) Pharmaco-EEG. Computer EEG analysis to describe the projection of drug effects on a functional cerebral level in humans. In F. Lopes da Silva et al. (Eds.), Handbook of Electroencephalography and Clinical Neurophysiology (Vol. 2). Elsevier, Amsterdam, pp. 385-445.
20. Hochim, D., Riemann, D., Zulley, J. and Berger, M. (1986) Initial REM sleep suppression by clomipramine: a prognostic tool for treatment response in patients with major depressive disorder. Biol. Psychiatry 21, 1217-1220.
21. Itil, T. (1974) Quantitative pharmaco-electroencephalography. In T. Itil (Ed.), Psychotropic Drugs and the Human EEG: Modern Problems in Pharmacopsychiatry, Vol. 8. Karger, Basel, pp. 43-75.
22. Itil, T. (1975) Digital computer period analyzed EEG in psychiatry and psychopharmacology. In G. Dolce and G. Kunkel (Eds.), CEAN-Computerized EEG Analysis. Gustav Fischer Verlag, Stuttgart, pp. 289-308.
23. Itil, T. and Itil, K. (1986) The significance of pharmacodynamic measurements in the assessment of bioavailability and bioequivalence of psychotropic drugs using CEEG and dynamic brain mapping. J. Clin. Psychiatry 47, 20-27 (9, Suppl.).
24. Janke, W. (1985) Clinical efficacy of drugs predicted from drug effects after short-term administration in animals, normal subjects and patients. Neuropsychobiology 13, 53-54.
25. John, E., Prichep, L. and Easton, P. (1987) Normative data banks and neurometrics: basic concepts, methods and results of norm construction in methods of analysis of brain electric and magnetic signals. In A. Gevins and A. Remond (Eds.), EEG Handbook (revised series, Vol. 1). Elsevier, Amsterdam.
26. Joyce, P. and Paykel, E. (1989) Predictors of drug response in depression. Arch. Gen. Psychiatry 46, 89-99.
27. Kocsis, J.H., Hanin, I., Bowden, C. and Brunswick, D. (1986) Imipramine and amitriptyline plasma concentrations and clinical response in major depression. Br. J. Psychiatry 148, 52-57.
28. Kupfer, D., Foster, F., Reich, L., Thompson, K. and Weiss, B. (1976) EEG sleep changes as predictors in depression. Am. J. Psychiatry 133, 622-626.
29. Maas, J., Kocsis, J., Bowden, C., Davis, J., Redmond, D., Hanin, I. and Robins, E. (1982) Pretreatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment. Psychol. Med. 12, 37-43.
30. Maas, J., Koslow, S., Katz, M., Bowden, C., Gibbons, R., Stokes, P., Robins, E. and Davis, J. (1984) Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs. Am. J. Psychiatry 141, 1159-1171.
31. Mandema, J. and Danhoff, M. (1992) Electroencephalogram effect measures and relationships between pharmacokinetics and pharmacodynamics of centrally acting drugs. Clin. Pharmacokin. 23, 191-215.
32. Muscettola, G., Potter, W., Pickar, D. and Goodwin, F. (1984) Urinary 3-methoxy-4 hydroxyphenylglycol and major affective disorders: a replicatid new findings. Arch. Gen. Psychiatry. 41, 337-342.
33. Pockberger, H., Rappelsberger, P., Petsche, H., Thau, K. and Kufferte, B. (1984) Computer-assisted EEG topography as a tool in the evaluation of actions of psychoactive drugs in patients. Neuropsychobiology 12, 183-187.
34. Rabkin, J.G., McGrath, P., Steart, J.W., Harrison, W., Markowitz, J.S. and Quitkin, F. (1986) Follow-up of patients who improved during placebo washout. J. Clin. Psychopharmacol. 6, 274-278.
35. Saletu, B. (1987) The use of pharmaco-EEG in drug profiling. In I. Hindmarch and P. Stonier (Eds.), Human Psychopharmacology: Measures and Methods, Vol. 1. Wiley, Chichester, pp. 173-200.
36. Sannita, W., Ottonello, D., Perria, B., Rosadini, G. and Timitilli, C. (1983) Topographic approaches in human quantitative pharmaco-electroencephalography. Neuropsychobiology 9, 66-72.
37. Svendsen, K. and Christensen, P. (1981) Duration of REM sleep latency as a predictor of effect of antidepressant therapy. Acta. Psychiatr. Scand. 64, 238-243.
38. Ulrich, G., Renfordt, E., Zeller, G. and Frick, K. (1984) Interrelation between changes in the EEG and psychopathology under pharmacotherapy for endogenous depression: a contribution to the predictor question. Pharmacopsychiatry 17, 178-183.
39. Ulrich, G., Renfordt, E. and Frick, K. (1986a) The topographical destruction of alpha activity in the resting EEG of endogenous-depressive in-patients with and without clinical response to pharmacotherapy. Pharmacopsychiatry 19, 272-273.
40. Ulrich, G., Renfordt, E. and Frick, K. (1986b) Electroencephalographic dynamics of vigilance and drug-response in endogenous depression: a comparison of patients treated with amitriptyline and pirlindole. Pharmacopsychiatry 19, 270-271.
41. Ulrich, G., Haug, H., Stieglitz, R. and Fahndrich, E. (1988) Are there distinct biochemical subtypes of depression? EEG characteristics of clinically defined on-drug responders and non-responders. J. Affect. Disord. 15, 181-185.
42. Van Praag, H. and De Mann, S. (1980) Depression, vulnerability and 5-hydroxytrptophan prophylaxia. Psychiatry Res. 3, 75-83.
43. Vasey, M. and Thayer, J. (1987) The continuous problem of false positives in repealed measures ANOVA in psychophysiology: a multivariate solution. Psychophysiology 24, 479-486.